Scarica l'app Stockscreener
0.373
9.47%
-0.039
Dopo l'orario di chiusura:
.37
-0.003
-0.80%
Lunai Bioworks Inc Borsa (LNAI) Ultime notizie
Lunai Bioworks to acquire CNS drug delivery platform and Alzheimer’s assets for $20M - MSN
Lunai Bioworks (NASDAQ: LNAI) asks shareholders to approve up to 1‑for‑30 reverse split - Stock Titan
Lunai Bioworks Inc (2Q50.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Lunai Bioworks Inc Com (LNAI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Lunai Bioworks Expands CNS Portfolio With $20M Acquisition - TipRanks
Lunai Bioworks Unveils $20M Preferred Investment and Debt-for-Equity Exchange to Advance CNS Assets - TradingView
Lunai Bioworks (NASDAQ: LNAI) secures $20M CNS Alzheimer’s deal and converts secured debt - Stock Titan
Lunai Bioworks completes $20M transaction to acquire BBB - MSN
Lunai Bioworks acquires CNS drug delivery tech for $20M By Investing.com - ca.investing.com
LNAI Stock Chart | LUNAI BIOWORKS INC (NASDAQ:LNAI) - ChartMill
Why did LNAI stock skyrocket over 130% pre-market today? - MSN
Microcap March Madness: LNAI, FAGI, VSA, LNKS Sweet 16 Underdog Watch - Barchart
Lunai Bioworks Acquires $20M in BBB Delivery Tech, CNS Alzheimer’s Assets from Clemann Group - Contract Pharma
Why did LNAI stock skyrocket over 130% pre-market today? | Tap to know more | Inshorts - Inshorts
Lunai Bioworks, Inc. (LNAI) Stock: No-Reset Convertible Deal Boosts CNS Drug Development Edge - parameter.io
What's Behind The Jump In Lunai Bioworks Stock? - Benzinga
Lunai Bioworks (LNAI) Acquires BBB Technology in $20M Deal - GuruFocus
Why Did LNAI Stock Surge Over 25% Today? - Stocktwits
Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications - Finviz
LNAI Enhances CNS Pipeline with Strategic Acquisition - GuruFocus
Why Did LNAI Stock Skyrocket Over 130% Pre-Market Today? - stocktwits.com
Lunai Bioworks acquires CNS drug delivery tech for $20M - Investing.com
Lunai Bioworks Executes $20M Strategic Transaction At Fixed $1.50 Conversion, Acquiring Bbb Delivery Platform For Cns Alzheimer's Therapies With Broad Cns Delivery Applications - TradingView
Lunai Bioworks Inc. has executed binding agreement to acquire BBB delivery technology and CNS Alzheimer's drug assets of Clemann Group from Clemann Group for $20 million. - MarketScreener
If You Invested $1,000 in Renovaro (RENB) - Stock Titan
$400M to $1.2 Billion US Countermeasures Program Presents Huge Opportunity for New AI Platform to Meet Emerging Battlefield and Terrorism Threats: Lunai Bioworks (Nasdaq: LNAI) - Barchart.com
$400M to $1.2 Billion US Countermeasures Program Presents Huge - openPR.com
Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI) - PRLog
Lunai Bioworks Engages Initial U.S. Countermeasure Opportunities Following $400M–$1.2B Consortium Launch - weeklyvoice.com
Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model - Finviz
LNAI Initiates Consortium to Speed Up Chemical Countermeasure De - GuruFocus
Lunai Bioworks (LNAI) Stock Forecast and Price Target 2026 $LNAI - MarketBeat
LNAI stock: Lunai Bioworks (NASDAQ) $0.52, vol 509,735,274 on 17 Mar 2026: monitor AI oncology signals - Meyka
Why Is This Micro-Cap Biotech Stock Up 150% Today? - Stocktwits
Best Manufacturing Stocks To Watch TodayMarch 17th - MarketBeat
Why Is LNAI Stock Skyrocketing Today? - Stocktwits
Top Biotech Stocks To Follow TodayMarch 17th - MarketBeat
Lunai Bioworks (LNAI) jumps 189% as traders refocus on recent IP update and looming Nasdaq listing decision - Quiver Quantitative
12 Health Care Stocks Moving In Tuesday's Pre-Market SessionAldeyra Therapeutics (NASDAQ:ALDX), Agape - Benzinga
Lunai Launches AI Safeguard Sentinel to Prevent Chemical Agent Generation - Intellectia AI
ENOB FINAL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class ActionENOB - marketscreener.com
12 Health Care Stocks Moving In Friday's Intraday SessionFirefly Neuroscience (NASDAQ:AIFF), AN2 Thera - Benzinga
Lunai Bioworks initiates employee furloughs and salary deferrals to preserve liquidity - Investing.com UK
Lunai Bioworks Furloughs Staff Amid Liquidity Constraints - TipRanks
Lunai Bioworks implements temporary furlough of employees in US and CanadaSEC filing - marketscreener.com
Lunai Bioworks implements temporary furloughs, execs defer salaries to preserve liquidity - TradingView
Financial Survey: Lunai Bioworks (NASDAQ:LNAI) versus Lite Strategy (NASDAQ:LITS) - Defense World
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - The Sheboygan Press
Lunai Bioworks Highlights Sentinel AI Safeguard After Anthropic CEO Warning on AI Chemical and Biological Threats - The Destin Log
LNAI Should I Buy - Intellectia AI
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):